Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.
1. STOCK NEWS:
- Twitter (TWTR) is suing Tesla (TSLA) founder Elon Musk for terminating their merger agreement [more]
- Delta (DAL) reported downbeat Q2 adjusted earnings [more]
- Unity Software (U) and ironSource (IS) agreed to merge in an all-stock deal [more]
- Fastenal (FAST) reported mostly in-line Q2 earnings and revenue [more]
- Netflix (NFLX) will partner with Microsoft (MSFT) on a new ad-supported subscription plan [more]
2. WALL STREET CALLS:
- DigitalOcean (DOCN) downgraded to Sell from Buy at Goldman Sachs [more]
- Shyft Group (SHYF) upgraded to Buy at DA Davidson on improving commercial van sales [more]
- Wells Fargo downgraded OneMain Holdings (OMF) and Synchrony (SYF) to Equal Weight [more]
- Juniper (JNPR) downgraded to Underweight from Neutral at Piper Sandler while being added to "Tactical Outperform" list at Evercore ISI [more]
- KeyBanc analyst Justin Patterson initiated coverage of Uber (UBER) and Lyft (LYFT) with Sector Weight ratings [more]
3. AROUND THE WEB:
- Apple (AAPL) and Jony Ive have terminated their consulting agreement, NY Times reports [more]
- Lufthansa (DLAKY) cut an additional 2,000 flights amid travel disruptions, Bloomberg reports [more]
- Oracle (ORCL) will pay $17.5M to settle a shareholder lawsuit, Reuters reports [more]
- Illumina (ILMN) lost its bid to block an EU watchdog review of its Grail deal, Bloomberg says [more]
- Brookfield (BAM) and DigitalBridge (DBRG) are teaming up over a bid for Deutsche Telekom's (DTEGY) towers unit, BLoomberg reports [more]
4. MOVERS:
- Gossamer Bio (GOSS) higher after announcing a $120M private placement financing [more]
- Stitch Fix (SFIX) increases after director Gurley purchased 1M shares [more]
- SIGA Technologies (SIGA) gains after announcing $28M of procurement orders for oral TPOXX [more]
- Atara Biotherapeutics (ATRA) falls after announcing it will not expand the sample size in its ATA188 Phase 2 study [more]
- Humanigen (HGEN) sinks after its NIAID ACTIV-5/BET-B trial evaluating lenzilumab plus remdesivir versus placebo plus remdesivir in hospitalized COVID-19 patients missed the primary endpoint [more]
5. EARNINGS/GUIDANCE:
- Polestar (PSNY) reaffirmed its revenue view for FY22 [more]
- Unity (U) cut its FY22 revenue guidance [more]
- ironSource (IS) reiterated its Q2 and FY22 guidance [more]
- Citi analyst Keith Horowitz upgraded JPMorgan (JPM) yesterday ahead of earnings coming from the bank this week [more]
- Morgan Stanley (MS) also set to report earnings Thursday [more]
INDEXES:
The Dow fell 208.54, or 0.67%, to 30,772.79, the Nasdaq lost 17.15, or 0.15%, to 11,247.58, and the S&P 500 declined 17.02, or 0.45%, to 3,801.78.